Company Quick10K Filing
Pacific Ventures
10-K 2019-12-31 Filed 2020-05-08
10-Q 2019-09-30 Filed 2019-11-15
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-20
10-K 2018-12-31 Filed 2019-04-11
S-1 2018-12-21 Public Filing
10-Q 2018-09-30 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-19
10-K 2016-12-31 Filed 2017-04-12
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-25
10-K 2015-12-31 Filed 2016-05-23
10-Q 2015-09-30 Filed 2015-11-25
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-02
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-07
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-30
8-K 2020-04-13 Amend Bylaw, Exhibits
8-K 2019-12-17 Other Events
8-K 2019-12-17 M&A, Sale of Shares, Regulation FD, Exhibits
8-K 2019-08-21 Regulation FD, Exhibits
8-K 2018-08-08 Other Events
8-K 2018-06-21 Officers
8-K 2018-06-20 Officers
8-K 2018-06-13 Other Events, Exhibits
8-K 2018-04-30 M&A, Off-BS Arrangement, Exhibits
8-K 2018-01-31 Enter Agreement, Exhibits
8-K 2017-07-12 Enter Agreement, Off-BS Arrangement, Sale of Shares

Pacific Ventures Financials

PACV Metrics, Comps, Filings

Quarterly | Annual

Business

Unless the context requires otherwise or unless otherwise stated, references to “our Company,” “Pacific Ventures,” “PACV,” “we,” “us,” “our” and similar references refer to Pacific Ventures Group, Inc. and its consolidated subsidiaries.

Pacific Ventures was incorporated under the laws of the State of Delaware on October 3, 1986, under the name AOA Corporation. On November 12, 1991, the Company changed its name to American Eagle Group, Inc. On October 22, 2012, the Company changed its name to Pacific Ventures Group, Inc.

The current structure of Pacific Ventures resulted from a share exchange with Snöbar Holdings, Inc. (“Snöbar”), which was treated as a reverse merger for accounting purposes. On August 14, 2015, Pacific Ventures and its stockholders entered into a share exchange agreement (the “Share Exchange Agreement”) with Snöbar Holdings, Inc. (“Snöbar Holdings”), pursuant to which Pacific Ventures acquired 100% of the issued and outstanding shares of Snöbar Holdings' Class A and Class B common stock in exchange for 22,500,000 restricted shares of Pacific Ventures' common stock, while simultaneously issuing 2,500,000 shares of Pacific Ventures' restricted common stock to certain other persons, including for services provided and to a former officer of the Company (the “Share Exchange”).As the result of the Share Exchange, Snöbar Holdings. became Pacific Venture's wholly owned operating subsidiary and the business of Snöbar Holdings became the Company's sole business operations, and Snöbar Holdings' majority owned subsidiary, MAS Global Distributors, Inc., a California corporation (“MGD”),became indirect subsidiary of Pacific Ventures.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Natcore Technology (NXT)
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
Amplitude Healthcare (AMHCU)
Galileo Acquisition (GLEO)
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
New You (NWYU)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
Electromedical Technologies (ELCQ)
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Anchiano Therapeutics (ANCN)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash010101000000000056752550024011474191198-1114
Accounts Receivable0107770220164280246244193
Inventory2000000066162161198371460
PP&E35343432302928112911911310610495
Assets0101010000000003992109608338603641,5251,8301,6681,5951,7951,799
Accounts Payable0205210223177175171146171226478501598628802832
Long-Term Debt6606609631,0767485346573122871,7902,1902,2592,2402,3322,332
Liabilities1229313745510361116202323331,4331,6931,7971,6471,4031,4041,5061,6681,7633,6254,1124,2514,2994,7375,073
Stockholders' Equity-12-28-31-37-44-500-3-6-11-16-20-23-23-33-1,395-1,601-1,688-1,587-1,320-1,343-1,446-1,632-1,759-2,100-2,283-2,583-2,704-2,942-3,273
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000006901,2191,2891,1271,098
Cost of Revenue004829131,010717904
Gross Profit140020100000208305279410194
R&D
SG&A1626856334633010-5628103901308211691167238279171246273259
Tax000000000000000000000000000
Net Income-16-2-6-8-5-5-3-3-4-6-3-3-0-10331-36-274-75-91-76-128-108-236-304-258-307-303-238-631
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-16-1-5-4-4-13-0-2-5-2-60-2-4-266-31-285-101-118-92-47-131-241-96-687-302-205-188-187
Cash Investing0020-74-5452
Cash Financing1606451102526024-5223134112068117-5157218971,936575136222160